Supernus Pharmaceuticals to Participate in September Investor Conferences
Supernus Pharmaceuticals, a biopharmaceutical company specializing in CNS disorder treatments, announced participation in September investor conferences including the Cantor Global Healthcare and Wells Fargo Healthcare conferences. Management will engage in fireside chats and provide webcasts to communicate corporate strategies and developments.